Arie Belldegrun

Co-Founder & Senior Managing Director at VV Manager LLC

Arie Belldegrun

Arie Belldegrun

Co-Founder & Senior Managing Director at VV Manager LLC

Overview
Career Highlights

Bellco Capital LLC
Two River Group Holdings LLC
Equinor ASA

RelSci Relationships

4947

Number of Boards

31

Birthday

1950

Age

71

Number of Awards

1

Contact Data
Trying to get in touch with Arie Belldegrun? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Arie Belldegrun likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Kirax Corporation

Relationship likelihood: Strong

Co-Founder at VV Manager LLC

Relationship likelihood: Strong

Venture Partner at Vida Ventures

Relationship likelihood: Strong

Founder at Bellco Capital LLC

Relationship likelihood: Strong

Founding Director at University of California, Los Angeles - Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at David Geffen School of Medicine at UCLA

Relationship likelihood: Strong

Co-Founder & Managing Partner at Pontifax Management Co. Ltd.

Relationship likelihood: Strong

Fund Advisor at TPG Global Advisors LLC

Relationship likelihood: Strong

Scientific Founder at Cell Design Labs, Inc.

Relationship likelihood: Strong

Co-Founder & Managing Director at VV Manager LLC

Relationship likelihood: Strong

Co-Founder & Managing Director at VV Manager LLC

Relationship likelihood: Strong

Paths to Arie Belldegrun
Potential Connections via
Relationship Science
You
Arie Belldegrun
Co-Founder & Senior Managing Director at VV Manager LLC
Family Members
Spouse
Founder at Bellco Capital LLC

Bellco Capital LLC provides investment advisory services. It focuses on deploying capital to create and support companies in life science, real estate, consumer products, media, and other sectors. The company was founded by Rebecka Belldegrun and Arie Belldegrun in 2003 and is headquartered in Los Angeles, CA.

Education
MD
Class of 1974

Hadassah Medical School is a provider of learning medical training and research institute.

Memberships
Fellow
Current

The primary exempt purpose is to improve the quality of care of the surgical patient through education and research.

Career History
Chairman, President & Chief Executive Officer
1988 - 1999

Equinor ASA engages in the exploration, production, transport, refining, and marketing of petroleum and petroleum-derived products. It operates through the following segments: Exploration and Production Norway; Exploration and Production International; Marketing, Midstream, and Processing; and Other. The Exploration and Production Norway segment includes the commercial development of oil and gas portfolios on the Norwegian continental shelf. The Exploration and Production International segment covers offshore and onshore activities in the USA, Mexico, and other operations worldwide. The Marketing, Midstream, and Processing segment markets and trades of oil and gas commodities. The Other segment includes new energy solutions; global strategy and business development; technology; projects and drilling; and corporate staffs and services. The company was founded on September 18, 1972 and is headquartered in Stavanger, Norway.

Research Fellow in Surgical Oncology & Immunotherapy
Prior - 1988

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.

Co-Founder
1996 - 2007

Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.

Boards & Committees
Executive Chairman of the Board
2017 - Current

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Chairman of the Board
2017 - Current

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic transcription factors, small cell, prostate cancer, and MYC-driven cancers. The company was founded by Angela Koehler and Joshua Kazam in 2017 and is headquartered in Cambridge, MA.

Chairman of the Board
2012 - Current

UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options. It has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. The firm's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's approved product, Jelmyto (mitomycin) for pyelocalyceal solution, and investigational treatment UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade non-muscle invasive bladder cancer, respectively. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Member of the Life Sciences & Management Advisory Board
Current

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Member, Board of Directors
Current
Chairman-Molecular Biological Technology Committee
Prior

American Urological Association Education & Research, Inc. operates a urologic association. It offers urological clinical care through education, research and the formulation of health care policy. The company was founded on February 22, 1902 and is headquartered in Linthicum, MD.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$2,500 - $4,999
2017

Henry Street Settlement, Inc. delivers social services and art programs. The company was founded in 1893 and is headquartered in New York, NY.

$1,000 - $2,499
2016

EMPOWERMENT OF CURRENT AND FORMER FOSTER YOUTH ON THEIR JOURNEY TO SELF-SUFFICIENCY.

$10K - $25K
2015

USC Shoah Foundation, formerly Survivors of the Shoah Visual History Foundation, is a nonprofit organization dedicated to making audio-visual interviews with survivors and witnesses of the Holocaust (which in Hebrew is called the Shoah) and other genocides, a compelling voice for education and action. It was established by Steven Spielberg in 1994, one year after completing his Academy Award-winning film Schindler's List.

Political Donations
$2,500
2012

Senator from South Carolina

$2,300
2007

Former Senator from New York

$25K
2004

The Republican National Committee (RNC) is a U.S. political committee that provides national leadership for the Republican Party of the United States. It is responsible for developing and promoting the Republican political platform, as well as coordinating fundraising and election strategy. It is also responsible for organizing and running the Republican National Convention. Similar committees exist in every U.S. state and most U.S. counties, although in some states party organization is structured by congressional district, allied campaign organizations being governed by a national committee. Reince Priebus is the current RNC Chairman.

Transactions
Details Hidden

Vida Ventures LLC raised money in a private placement transaction

Details Hidden

Kite Pharma, Inc. raised money in a private placement transaction

Investments
Details Hidden

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic transcription factors, small cell, prostate cancer, and MYC-driven cancers. The company was founded by Angela Koehler and Joshua Kazam in 2017 and is headquartered in Cambridge, MA.

Details Hidden

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Details Hidden

Arno Therapeutics, Inc. is a biopharmaceutical company, which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. The company was founded in March 2000 and is headquartered in Tualatin, OR.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
American Board of Urology - Board Certification in Pediatric Urology
Events
Speaker
Los Angeles, CA, United States
2013 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Arie Belldegrun. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Arie Belldegrun's profile does not indicate a business or promotional relationship of any kind between RelSci and Arie Belldegrun.